12 Kempton Place, Apt. 4. · Saratoga Springs, NY 12866
Phone: 518-682-2227 · Fax: 413-682-2221
Email:
keith@croes.com
March to July 2008—Director, Scientific
Services, The Selva Group, Saratoga
Springs, NY
·
Supervised
production of editorial deliverables for The Selva Group, a medical education
and events management company and division of inVentiv Health (Nasdaq: VTIV)
·
Managed
staff of full-time and freelance advanced-degree writers
·
Worked
with account teams to analyze competitive landscape and respond to RFPs in new
therapeutic areas
·
In
business unit reorganization, several senior positions were eliminated,
including director of scientific services
2001 to 2007—President, Croes Communications, Inc., Oak Hall, VA
·
Orchestrated
the production of editorial deliverables targeted to medical professionals and
consumers
·
Developed
new business; oversaw budget and sales projections; provided day-to-day
management of nationwide network of independent contractors (writers, editors,
artists)
·
Sold
company in December 2007 to startup medical communications firm needing an
editorial division
1999 to
2001—Editorial Director, HealthVizion Medical Communications, Parsippany, NJ
·
Supervised
production of supplements, journal articles, periodicals, and other editorial
tactics as part of communications campaigns for major pharmaceutical and device
companies
·
Designed
and implemented tracking system for editorial projects
·
Managed
staff of freelance and full-time writers, editors, and artists
1998 to
1999—Managing Medical Editor, Discovery International, Parsippany, NJ
·
Wrote
journal articles, monographs, white papers, executive summaries, and
professional slide presentations
·
Participated
in national and regional advisory board meetings, working closely with key
opinion leaders on all editorial initiatives
1996 to 1998—
Executive Editor, EyeWorld News Service, Princeton, NJ
·
Launched
monthly newsmagazine, EyeWorld, in October 1996
·
Directed
full-time staff and worldwide network of freelance writers, editors, and
artists
·
Supervised
design, function, and maintenance of interactive website and e-based
subscription news service
1982 to 1996—
Editor-in-Chief, Slack Medical Publishing, Thorofare, NJ
·
Served
as editor-in-chief (1994-1996), executive editor (1986-1994), managing editor
(1984-1986) and associate editor (1982-84) of Ocular Surgery News, a
twice-monthly newsmagazine and the leading publication in ophthalmology
·
Supervised
launch of Ocular Surgery News International Edition, a monthly
newsmagazine distributed in Europe, Australia, Japan, Latin America, and
Pacific Rim countries.
·
Proficient
with Microsoft Office programs, Quark, and publication planning software used
by Fortune 500 pharmaceutical and biotech companies
·
Experienced
in orchestrating the development of print and electronic editorial products for
professionals and consumers
·
Accustomed
to playing key role in capturing new business and projecting and managing budgets
and production processes
·
Able
to operate professionally and efficiently in team environment as member or
leader
·
Adept
at working with product and marketing teams at major drug and device companies
to establish and reach communications goals
·
Meticulous
in maintaining accuracy, enforcing editorial style, and meeting deadlines
·
Proven
successful in establishing and cultivating relationships with key figures in
target communities
·
Versed
in relevant regulations and guidelines for medical communications and education
·
With
Croes Communications, contracted to serve as editorial director on the pitch
for the U.S. publication plan of Actemra™ (tocilizumab, Roche). Analyzed the
competitive landscape, which included a comprehensive literature review, and
developed the pitch deck. Competing with four other medical communications
companies, the client (a new U.S. subsidiary of a Swiss medical communications
company) was awarded the business, representing a $4 million engagement
·
Sold
Croes Communications in December 2007 to a startup medical communications firm
needing an editorial division. Croes Communications had annual revenues
averaging $500,000 from 2001 to 2006
·
Played
key role in development and implementation of publication plans for three major
brands
·
Served
as editorial director for the publication plan of Aranesp® (darbepoetin alfa, Amgen) beginning in
Phase 3 through launch. The publication plan included tactics such as a
quarterly journal (CKD, the Journal of
Chronic Kidney Disease), a case-based quarterly CME newsletter (Profiles in Chronic Kidney Disease),
peer-reviewed journal articles, a supplement to the American Journal of Kidney Disease, a supplement to Internal Medicine News, a monograph on
the disease state (“The Renal Anemia Management Period”), and management of a
KOL Web site. The $4 million engagement included participation in strategy and
messaging. Aranesp sales rose to more than $3 billion annual global revenues in
the years after launch
·
Was
a founding staff member of a startup specialty periodical (Ocular Surgery News), serving as the lead editor and rising to the
position of editor-in-chief. In a competitive space of about 20 competing
journals, Ocular Surgery News gained
market share every year for 14 years, becoming the leading publication in the
field, in terms of both readership and advertising, within 7 years of launch.
Oversaw multimillion-dollar editorial budgets and staff of up to 10 direct
reports. Cultivated high morale, productivity, and motivation with low staff
turnover over 14-year period
·
Developed
agendas, invited faculty, and moderated publication-sponsored medical meetings
held at venues throughout the world
Diabetes—Wrote numerous executive summaries,
newsletters, and journal supplements targeted to endocrinologists,
pediatricians, and primary care providers. Conducted comprehensive literature
and market analyses in responding to an RFP related to the global publication
plan for a new SGLT-2 inhibitor; developed pitch presentation in collaboration
with science and account teams.
Psychopharmacology—Wrote and developed speakers’ bureau
slide decks for Seroquel® (quetiapine, AstraZeneca) through a series
of national and regional KOL advisory boards; conducted literature reviews and
wrote competitive analyses in the areas of schizophrenia, bipolar disorder,
depression, and anxiety; managed the AstraZeneca slide library. Edited and
orchestrated the development of numerous journal articles, abstracts, and
posters related to medications for treating attention-deficit hyperactivity
disorder.
Rheumatology and immune-mediated
inflammatory diseases—Served
as editorial director on the publication plan (Phase 3 through launch) for
Kineret® (anakinra, Amgen). Wrote and developed speakers’ bureau
slide decks for Enbrel® (etanercept, Amgen-Wyeth) through a series
of national and regional KOL advisory boards. Wrote slide decks on inflammatory
cytokine inhibition related to psoriasis, psoriatic arthritis, Crohn’s disease,
and other disorders.
Ophthalmology—Served as editor-in-chief of leading
specialty periodical. Wrote numerous articles on refractive surgery for the
consumer Web site, AllAboutVision.com. Wrote Allergan internal training
programs in the areas of age-related macular degeneration and diabetic
retinopathy and their treatment through phototherapy combined with vascular
endothelial growth factor inhibition. Facilitated the 2007 publication of the
book, “Birth of the Intraocular Lens,” edited by Herve Byron, MD, with
contributions from 28 leading ophthalmologists.
Other categories—Wrote, edited, and supervised the
creation of a wide variety of editorial deliverables in numerous other
categories, such as cardiology, neurology, oncology, pain management, obesity
(bariatric surgery), dermatology, immunology, infectious diseases, and
nephrology (see attached list of Croes Communications projects).
1990 through 1996—Industry-Sponsored
Courses
Certifications
in PowerPoint, Quark, and MS Office programs
1978—Pennsylvania
State University,
University Park, PA
BA,
communications
1976—Vincennes
University,
Indianapolis, IN
Course work in
macro- and microeconomics
1974—Defense
Information School, Indianapolis,
IN
Top graduate in
DINFOS print journalism and public information/affairs course
Member: American Medical Writers Association; Global Alliance for
Medical Education; Board of Trustees of the Council for Refractive Surgery
Quality Assurance
Croes Communications Project Work – Partial List
|
Bariatric Surgery |
||||||
|
Type of Project |
Disease |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|
Journal supplement |
Obesity |
Laparoscopic adjustable
gastric banding in bariatric surgery: an overview of the LAP-BAND |
Inamed |
LAP-BAND |
Am J Surg |
N |
|
|
||||||
|
Cardiology |
||||||
|
Type of Project |
Pathology |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|
Slide deck |
Peripheral arterial disease |
Peripheral
arterial disease |
Otsuka |
cilostazol |
NA |
Y |
|
Monograph |
Hypertension |
Angiotensin
receptor blockade in cardiovascular medicine: new considerations for the
clinical cardiologist |
Biovail |
eprosartan |
NA |
Y |
|
Monograph |
Advanced heart failure |
Advanced
Heart Failure Today |
Thoratec |
HeartMate II Left
Ventricular Assist System |
NA |
N |
|
Dermatology |
||||||
|
Type of Project |
Disease |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|
Review article |
Psoriasis |
The interleukin-12 family
of cytokines: therapeutic targets for inflammatory disease mediation |
Centocor |
CNTO 1275 |
Clin Applied Immunol Rev |
N |
|
Slide decks |
Psoriasis |
Beyond
the T-Cell: the IL-12 family and its role in immune-mediated inflammatory
diseases |
Centocor |
CNTO 1275 |
Case Western University |
Y |
|
Journal supplement |
Acne and rosacea |
Nicotinamide
and zinc in the treatment of acne and rosacea |
Sirius Laboratories |
Nicomide |
Cutis |
N |
|
Review article |
Onychomycosis |
Defining
cure for toenail onychomycosis: consensus conference report |
Novartis |
Lamisil |
J Am Acad Dermatol |
N |
|
Journal supplement |
Psoriasis, atopic
dermatitis |
New
strategies for optimizing the treatment of inflammatory
dermatoses with corticosteroids in an era of corticosteroid-sparing regimens |
Connetics |
betamethasone valerate,
clobetasol propionate |
J Am Acad Dermatol |
N |
|
Executive summary |
Inflammatory skin
conditions, UV-induced erythema |
Scientific
Council on Education: A Focus on Feverfew PFE |
J&J Consumer |
Feverfew PFE |
NA |
N |
|
Monograph |
Actinic keratosis |
Actinic
keratosis: what you must know about prevention, diagnosis, and treatment |
Dermik
Laboratories/Sanofi-Aventis |
fluorouracil cream |
NA |
Y |
|
|
||||||
|
Endocrinology |
|||||||||
|
Type of Project |
Pathology |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|||
|
Executive summary |
Diabetes |
Novo Nordisk |
insulin aspart |
NA |
N |
||||
|
Slide decks |
Diabetes |
Advisory board
presentations |
Novo Nordisk |
insulin aspart, insulin
detemir |
NA |
N |
|||
|
Supplement |
Diabetes |
Outpatient
insulin therapy in diabetes mellitus |
Novo Nordisk |
insulin detemir |
Internal Medicine News |
N |
|||
|
Newsletter |
Diabetes |
Keeping in step with type 2
diabetes: the role of the β- and endothelial cells in the progression of
type 2 diabetes |
Aventis |
glimepiride |
NA |
N |
|||
|
Executive summary |
Hypothyroidism |
Cytomel Advisory Board
Meeting |
King Pharmaceuticals |
Cytomel |
NA |
N |
|||
|
|
|||||||||
|
Immunology |
|||||||||
|
Type of Project |
Disease |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|||
|
Slide decks |
Rheumatoid arthritis,
Crohn’s, psoriasis |
Immunology
Grand Rounds |
Amgen, Wyeth |
etanercept |
NA |
Y |
|||
|
|
|||||||||
|
Infectious diseases |
|||||||||
|
Type of Project |
Disease |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|||
|
Slide decks |
Pneumonia, bronchitis,
rhinosinusitis |
Presentations
for lecture series |
Aventis |
telithromycin
|
NA |
Y |
|||
|
|
||||||
|
Nephrology |
||||||
|
Type of Project |
Pathology |
Title/Description |
Sponsor |
Drug/Device |
Journal/Meeting |
CME (Y/N) |
|
Slide decks |
Anemia of chronic kidney
disease |
Slide resource and lecture
series |
Amgen |
epoetin alfa, darbepoetin
alfa |
NA |
N |
|
Journal supplement |
Anemia of chronic kidney
disease |
Anemia in the elderly: what
more should we be doing? |
Amgen |
epoetin alfa, darbepoetin
alfa |
||